Fingerprint
Dive into the research topics of 'Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib
Anneleen Daemen, Denise M. Wolf, James E. Korkola, Obi L. Griffith, Jessica R. Frankum, Rachel Brough, Lakshmi R. Jakkula, Nicholas J. Wang, Rachael Natrajan, Jorge S. Reis-Filho, Christopher J. Lord, Alan Ashworth, Paul T. Spellman, Joe W. Gray, Laura J. Van'T Veer
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Section of Bone Marrow Transplant & Leukemia
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Section of Stem Cell Biology
- DBBS - Molecular Cell Biology
- DBBS - Biomedical Informatics and Data Science
- DBBS - Cancer Biology
- Brain Tumor Center
- DBBS - Immunology
Research output: Contribution to journal › Article › peer-review
67
Scopus
citations